14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:AGLE
Delisted

Aeglea BioTherapeutics Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$12.01
+0 (+0%)
At Close: Feb 26, 2024
Forecast Fundamentals Insider Trading Signals Historical Prices Predictions News Profile
Currently predicting for Mon, 20 May 2024

AGLE Predictions History

5 years ago
 NameNotImportant predicted that AGLE for 2019-05-06 is going $6.97 (-0.43%)

Click to get the best stock tips daily for free!

About Aeglea BioTherapeutics

Aeglea BioTherapeutics Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy for the treatment of Arginase 1 deficiency. It also develops AGLE-177, a polyethylene glycol modified, w... AGLE Profile

Golden Star

Ticker Date Change Price
LYV May 15 0.114% $96.48
RL May 15 0.539% $166.98
PAGS May 15 0.157% $12.74
EVBG May 15 0.230% $34.79
INBX May 15 0.96% $34.37
CME May 14 1.11% $210.80
VGIT May 14 0.173% $57.83
VCLT May 14 0.726% $75.73
BNDX May 14 0.267% $48.60
FIXD May 14 0.303% $42.89
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT